PharmaShots | Incisive News in 3 Shots

Subscribe Now

pharma

MIRA Pharmaceuticals & MIRALOGX Entered into an Exclusive Licensing Agreement for Ketamir-2

MIRA Pharmaceuticals & MIRALOGX Entered into an Exclusive Licensing Agreement for Ketamir-2

November 21, 2023

Boundless Bio Entered into a Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate Lytgobi + BBI-355 for FGFR Amplified Solid Tumors

Boundless Bio Entered into a Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate Lytgobi + BBI-355 f...

September 19, 2023

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

September 4, 2023

Pharma Tech Conclave 2023

Pharma Tech Conclave 2023

February 22, 2023

Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

January 30, 2023

Intas Entered into an Exclusive License Agreement with Syna to Commercialize Biosimilar LB-0702

Intas Entered into an Exclusive License Agreement with Syna to Commercialize Biosimilar LB-0702

November 3, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us